Please update your Flash Player to view content.
Welcome to M2M
Home PDF Print E-mail
Global Economy, Global Organisations, Global Brands, Global Teams equals Global Regulatory Consultancy
Regulatory Affairs consultancy for the Biologic & Pharmaceutical Industry: All aspects of the Global Drug Development Continuum
 Strategic; Collaborative; Delivery; Education/ Training

  • Our Business Partners are currently predominantly Blue Chip Big Pharma.  Therefore, molecule2marketplace can bring extensive Corporate experience of working in Global ‘virtual’ Matrix Organisations for maximum operational excellence.
  • Molecule2marketplace Business Partners also include other UK based Regulatory Consultancy Companies.

Future Regulatory challenges: Navigating the dynamic regulatory environment

The Regulatory environment is constantly shifting & is littered with many challenges & potential pitfalls.

The below are some of the many future challenges you may have to consider.  “Have we already successfully navigated where you want to go?”

1. The evolving Regulatory environment (e.g. New Pharmacovigilance Legislation)
2. Guidance: Regulation: Law
3. Pharmaco-genomics (personalised medicine)
4. Risk/ Benefit considerations & Global Communications
5. Divergence in Emerging Markets balanced with the dichotomy of increased Global convergence
6. Evolving Clinical Trial design(s)
7. Adapting to the shifting political landscape (e.g. US)
8. Increased pricing & reimbursement challenges
9. Global media communications
10. Adapting to constant Scientific Innovation(s)

Working together to accelerate drug development